Preferred Stock, Shares Authorized of NGM BIOPHARMACEUTICALS INC from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
NGM BIOPHARMACEUTICALS INC quarterly Preferred Stock, Shares Authorized history and change rate from Q4 2018 to Q4 2023.
  • NGM BIOPHARMACEUTICALS INC Preferred Stock, Shares Authorized for the quarter ending 31 Dec 2023 was 10,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Change (%)

NGM BIOPHARMACEUTICALS INC Quarterly Preferred Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 10,000,000 0 0% 31 Dec 2023 10-K 11 Mar 2024 2023 FY
Q3 2023 10,000,000 0 0% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 10,000,000 0 0% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 10,000,000 0 0% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 10,000,000 0 0% 31 Dec 2022 10-K 11 Mar 2024 2023 FY
Q3 2022 10,000,000 0 0% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 10,000,000 0 0% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 10,000,000 0 0% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 10,000,000 0 0% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 10,000,000 0 0% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 10,000,000 0 0% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 10,000,000 0 0% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 10,000,000 0 0% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 10,000,000 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 10,000,000 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 10,000,000 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 10,000,000 0 0% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q4 2018 10,000,000 31 Dec 2018 10-K 17 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.